Literature DB >> 17206559

Protective effect of glycyrrhizin, glycyrrhetic acid and matrine on acute cholestasis induced by alpha-naphthyl isothiocyanate in rats.

Desheng Zhai1, Ying Zhao, Xijing Chen, Jiqiang Guo, Hui He, Qiaoling Yu, Jinnan Yang, Andrew K Davey, Jiping Wang.   

Abstract

Alpha-naphthyl isothiocyanate (ANIT) is a known hepatotoxicant that causes acute cholestatic hepatitis characterized by the infiltration of neutrophils around bile ducts and necrotic hepatocytes. The effects of glycyrrhizin (GL), 18beta-glycyrrhetinic acid (GA), matrine (MT), oxymatrine (OMT), salvianolic acid B (SAB), silymarin (SI) and dexamethasone (DEX) on ANIT-induced acute cholestasis in rats were investigated. Serological and histological data demonstrated that the administration of GL, GA or MT all protected against hepatocyte injury and cholestasis induced by ANIT. Furthermore, the bile flow and the accumulative bile excretion of ketoprofen glucuronide (KPG), that were significantly suppressed by ANIT, were preserved in rats administered GL, GA or MT. DEX protected against acute cholestasis but did not protect against hepatocyte necrosis and elevated serum alanine aminotransferase levels following ANIT administration. Rats administrated OMT, SAB or SI were not resistant to ANIT toxicity. In summary, the protective effect of DEX is directed toward cholangiocytes rather than hepatocytes whereas the natural products, GA, GL and MT, exhibit significantly better protective effects against ANIT-induced liver damage including the protection of hepatocytes as well as cholangiocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17206559     DOI: 10.1055/s-2006-957067

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  8 in total

1.  18β-Glycyrrhetinic acid protects against alpha-naphthylisothiocyanate-induced cholestasis through activation of the Sirt1/FXR signaling pathway.

Authors:  Shou-Yan Wu; Shi-Chao Cui; Le Wang; Yi-Ting Zhang; Xiao-Xia Yan; Heng-Lei Lu; Guo-Zhen Xing; Jin Ren; Li-Kun Gong
Journal:  Acta Pharmacol Sin       Date:  2018-07-30       Impact factor: 6.150

2.  Glycyrrhizin and glycyrrhetinic acid inhibits alpha-naphthyl isothiocyanate-induced liver injury and bile acid cycle disruption.

Authors:  Haina Wang; Zhong-Ze Fang; Ran Meng; Yun-Feng Cao; Naoki Tanaka; Kristopher W Krausz; Frank J Gonzalez
Journal:  Toxicology       Date:  2017-05-24       Impact factor: 4.221

3.  Glycyrrhizin ameliorates metabolic syndrome-induced liver damage in experimental rat model.

Authors:  Rajarshi Sil; Doel Ray; Abhay Sankar Chakraborti
Journal:  Mol Cell Biochem       Date:  2015-09-23       Impact factor: 3.396

Review 4.  Research progress on the protective effects of licorice-derived 18β-glycyrrhetinic acid against liver injury.

Authors:  Shou-Yan Wu; Wen-Jie Wang; Jin-Hui Dou; Li-Kun Gong
Journal:  Acta Pharmacol Sin       Date:  2020-03-06       Impact factor: 6.150

5.  Simultaneous Determination of 8 Compounds in Gancao-Ganjiang-Tang by HPLC-DAD and Analysis of the Relations between Compatibility, Dosage, and Contents of Medicines.

Authors:  Yanfang Yang; Guijun Zhang; Qiyu Sun; Liang Liu; Hui Peng; Jingjuan Wang; Li Xiang
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-14       Impact factor: 2.629

6.  Identification of the Mechanism of Matrine Combined with Glycyrrhizin for Hepatocellular Carcinoma Treatment through Network Pharmacology and Bioinformatics Analysis.

Authors:  Tao Han; Yiming Liu; Yutong Chen; Tingsong Chen; Yifan Li; Qiuhua Li; Mingfang Zhao
Journal:  Oxid Med Cell Longev       Date:  2022-09-19       Impact factor: 7.310

7.  Correlation analysis between the rate of respiration in the root and the active components in licorice (Glycyrrhiza uralensis).

Authors:  Peijun Guo; Zhirong Sun; Wenlan Liu; Long Chen; Yuan DU; Xinxin Wei
Journal:  Exp Ther Med       Date:  2013-11-07       Impact factor: 2.447

8.  Evaluation of the Percutaneous Absorption of Drug Molecules in Zebrafish.

Authors:  Daizo Morikane; Liqing Zang; Norihiro Nishimura
Journal:  Molecules       Date:  2020-08-31       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.